Rankings
▼
Calendar
RNA FY 2024 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
RNA
Avidity Biosciences, Inc.
$2B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$11M
+14.0% YoY
Gross Profit
$11M
100.0% margin
Operating Income
-$379M
-3477.4% margin
Net Income
-$322M
-2957.7% margin
EPS (Diluted)
$-2.89
Cash Flow
Operating Cash Flow
-$301M
Free Cash Flow
-$308M
Stock-Based Comp.
$51M
Balance Sheet
Total Assets
$1.6B
Total Liabilities
$139M
Stockholders' Equity
$1.4B
Cash & Equivalents
$220M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11M
$10M
+14.0%
Gross Profit
$11M
$7M
+46.1%
Operating Income
-$379M
-$236M
-60.8%
Net Income
-$322M
-$212M
-51.9%
← Q4 2023
All Quarters
Q1 2024 →